Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis

Journal of the National Cancer Institute

Volumn 99, Issue 3, 2007, Pages 223-235

  Nakayama, Takayuki ^a   Mutsuga, Noriko ^b   Tosato, Giovanna ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; ALPHA CHEMOKINE; COMPLEMENTARY DNA; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL GROWTH; CELL LEVEL; CELL LINEAGE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLENOMEGALY; STROMA CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; DISEASE MODEL; DNA MICROARRAY; FLOW CYTOMETRY; GENETICS; HEMATOPOIESIS; METABOLISM; METHODOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELLS, CULTURED; CHEMOKINES, CXC; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HEMATOPOIESIS; HUMANS; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECOMBINANT PROTEINS; RESEARCH DESIGN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33847749471     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk031     Document Type: Article

References (45)

1. Spivak JL. The chronic myeloproliferative disorders: clonality and clinical heterogeneity. Semin Hematol 2004; 41 Suppl 3:1-5.
2. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005;7:387-97.
3. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352:1779-90.
4. Xu M, Bruno E, Chao J, Ni H, Lindgren V, Nunez R, et al. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis. Blood 2005;105:1699-705.
5. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000; 342:1255-65.
6. Vannucchi AM, Bianchi L, Paoletti F, Pancrazzi A, Torre E, Nishikawa M, et al. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-betal in the development of myelofibrosis. Blood 2005;105: 3493-501.
7. Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood 2002;100:3495-503.
8. Burgess WH, Maciag T. The heparin-binding(fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
9. Nagasawa T, Nakajima T, Tachibana K, Iizasa H, Bleul CC, Yoshie O, et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci U S A 1996;93:14726-9.
10. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and RSDF-1-deficient mice. Proc Nad Acad Sci U S A 1998;95:9448-53.
11. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-9.
12. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow micro environment. Immunity 1999;10:463-71.
13. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002;99:2703-11.
14. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004;20:707-18.
15. Lataillade JJ, Clay D, Dupuy C, Rigal S, Jasmin C, Bourin P, et al. Chemokine RSDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000; 95:756-68.
16. Broxmeyer HE, Cooper S, Kohli L, Hangoc G, Lee Y, Mantel C, et al. Transgenic expression of stromal cell-derived factor-l/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol 2003;170:421-9.
17. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, et al. G-CSF induces stem cell mobilization by decreasing bone marrow RSDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3:687-94.
18. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD-3100, a CXCR4 antagonist. Blood 2003;102:2728-30.
19. Levesque JP, HendyJ, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest2003;lll:187-96.
20. Suzuki J, Fujita J, Taniguchi S, Sugimoto K, Mori KJ. Characterization of murine hemopoietic-supportive(MS-1 and MS-5) and non-supportive(MS-K) cell lines. Leukemia 1992;6:452-8.
21. Nakayama T, Yao L, Tosato G. Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J Clin Invest 2004; 114:1317-25.
22. Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L. A murine stromal cell line allows the proliferation of very primitive human CD34++/ CD38- progenitor cells in long-term cultures and semisolid assays. Blood 1993;81:2916-24.
23. Xiang CC, Kozhich OA, Chen M, Inman JM, Phan QN, Chen Y, et al. Amine-modified random primers to label probes for DNA microarrays. Nat Biotechnol 2002;20:738-12.
24. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C. "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 1990;249:1561-1-.
25. Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M, et al. Stromal cell-derived factor-1 alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 1999; 274:23916-25.
26. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A, et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003;102:906-15.
27. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine(BRAK) in macrophage development. J Exp Med 2001;194:855-61.
28. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C(4) transporter MRP1 regulates CCL19(MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000;103:757-68.
29. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989;83:1701-9.
30. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 1991;77:954-60.
31. Gabrilove JL, White K, Rahman Z, Wilson EL. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 1994;83:907-10.
32. Novitzky N, Makgoka SJ, Mohamed R. Basic fibroblast growth factor corrects proliferative derangement of bone marrow stroma and CD34(+) population following allogeneic stem cell transplantation. Exp Hematol 2001;29:1432-8.
33. Kashiwakura I, Takahashi TA. Basic fibroblast growth factor-stimulated ex vivo expansion of haematopoietic progenitor cells from human placental and umbilical cord blood. Br J Haematol 2003;122:479-88.
34. Dooley DC, Oppenlander BK, Spurgin P, Mead JH, Novak FP, Plunkett M, et al. Basic fibroblast growth factor and epidermal growth factor down- modulate the growth of hematopoietic cells in long-term stromal cultures. J Cell Physiol 1995;165:386-97.
35. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003;34:70-1.
36. Friedman HD, Sanderson SO, Stein CK, Shrimpton A, Gonchoroff NJ, Zamkoff KW, et al. Extra medullary granulopoiesis mimicking recurrent lymphoma after prolonged administration of human recombinant granulocyte colony-stimulating factor. Ann Hematol 1998;77: 79-83.
37. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9:60-13.
38. Aziz KA, Till KJ, Chen H, SlupskyJR, Campbell F, CawleyJC, et al. The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy- cell leukemia(HCL). Blood 2003;102:1051-6.
39. Shehata M, Schwarzmeier JD, Hilgarth M, Hubmann R, Duechler M, Gisslinger H. TGF-betal induces bone marrow reticulin fibrosis in hairy cell leukemia. J Clin Invest 2004;113:676-85.
40. Basu S, Broxmeyer HE. Transforming growth factor-{beta}l modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/ CXCL12. Blood 2005;106:485-93.
41. Wright N, de Lera TL, Garcia-Moruja C, Lillo R, Garcia-Sanchez F, Caruz A, et al. Transforming growth factor-betal down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 2003;102:1978-84.
42. Chklovskaia E, Jansen W, Nissen C, Lyman SD, Rahner C, Landmann L, et al. Mechanism of flt3 ligand expression in bone marrow failure: translocation from intracellular stores to the surface of T lymphocytes after chemotherapy- induced suppression of hematopoiesis. Blood 1999;93:2595-604.
43. Landreth KS, Narayanan R, Dorshkind K. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 1992;80:1207-12.
44. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001;194:45-56.
45. Narazaki M, Tosato G. Canstatin: an inhibitor of angiogenesis and tumor growth revisited. J Nad Cancer Inst 2006; 12:110-2.